Recent Updates
Recently added Catalysts
AMRX Positive Sentiment

Amneal to Participate in Goldman Sachs 47th Annual Global Healthcare Conference 2026

Key Takeaway: Amneal Pharmaceuticals will participate in the Goldman Sachs 47th Annual Global Healthcare Conference from June 8-10, 2026. Chirag Patel, Co-CEO, will present on June 9 at 8:40 AM EDT. This event offers Amneal an opportunity to highlight its diverse portfolio of medicines and engage with investors.
Price reaction · baseline $13.17 (2026-05-29 close) · 1 other AMRX headline(s) in the window, move may be shared
day 0 close · peak
-2.1%

Market Sentiment Analysis

POSITIVE FACTORS

  • Amneal is participating in a prestigious healthcare conference.
  • The event provides a platform for Amneal to showcase its innovations.
  • Chirag Patel's presentation may enhance investor interest.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+90%
120-day peak, hindsight
Typical move
3.6%
average across 12 past catalysts
Cash runway
~19 mo
Low dilution risk
Lead asset
Mometasone Furoate
Phase 3 · Seasonal Allergic Rhinitis

Full Press Release Details

BRIDGEWATER, N.J., June 01, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”), today announced that Chirag Patel, Co-Chief Executive and President, will participate and present at Goldman Sachs 47thAnnual Global Healthcare Conference 2026 being held on June 8-10 at the Loews Miami Beach Hotel in Miami, FL.
A company presentation will take place on Tuesday June 9, 2026, at 8:40AM EDT. A live webcast of the presentation will be availablehere.
About AmnealAmneal Pharmaceuticals, Inc. (Nasdaq: AMRX), headquartered in Bridgewater, New Jersey, is a diversified, global biopharmaceutical leader focused on expanding access to affordable and innovative medicines. Amneal was founded in 2002 by brothers and co-CEOs Chirag and Chintu Patel, and built on the belief that innovation only matters if it’s accessible. Today, Amneal has a diverse and growing portfolio of approximately 300 complex generic, specialty and biosimilar medicines, delivering more than 160 million prescriptions annually, primarily in the United States. Our Affordable Medicines segment spans retail generics, injectables, and biosimilars. Our Specialty segment provides branded treatments in neurology, including Parkinson’s disease and migraine, and endocrinology. Our AvKARE segment distributes pharmaceuticals and medical products to U.S. federal, retail, and institutional customers. For additional information, please visit amneal.com and follow us on LinkedIn.

Investor ContactAnthony DiMeoVP, Investor Relationsanthony.dimeo@amneal.com

Media ContactBrandon SkopSr. Director, Corporate Communicationsbrandon.skop@amneal.com

Frequently Asked Questions

When is Amneal's presentation at the conference?

Amneal's presentation is scheduled for June 9, 2026, at 8:40 AM EDT.

Where is the Goldman Sachs conference being held?

The conference will take place at the Loews Miami Beach Hotel in Miami, FL.

Who will represent Amneal at the conference?

Chirag Patel, Co-Chief Executive and President, will represent Amneal.

What is the focus of Amneal Pharmaceuticals?

Amneal focuses on expanding access to affordable and innovative medicines.

Last updated: Jun 1, 2026